Radiation dose to nuclear medicine technologists when operating PET/MR compared with PET/CT.


Journal

Journal of radiological protection : official journal of the Society for Radiological Protection
ISSN: 1361-6498
Titre abrégé: J Radiol Prot
Pays: England
ID NLM: 8809257

Informations de publication

Date de publication:
27 04 2022
Historique:
received: 03 02 2022
accepted: 16 03 2022
pubmed: 18 3 2022
medline: 30 4 2022
entrez: 17 3 2022
Statut: epublish

Résumé

Since 2010, positron emission tomography/magnetic resonance (PET/MR) has been increasingly used as clinical routine in nuclear medicine departments. One advantage of PET/MR over PET/computed tomography (CT) is the lower dose of ionising radiation delivered to patients. However, data on the radiation dose delivered to staff operating PET/MR compared with the new generation of PET/CT equipment are still lacking. Our aim was to compare the radiation dose to nuclear medicine technologists performing routine PET/MR and PET/CT in the same department. We retrospectively measured the daily radiation dose received by PET technologists over 13 months by collecting individual dosimetry measurements (from electronic personal dosimeters). Data were analysed taking into account the total number of studies performed with each PET modality (PET/MR with Signa 3T, General Electric Healthcare versus PET/CT with Biograph mCT flow, Siemens), the type of exploration (brain versus whole-body PET), the

Identifiants

pubmed: 35296565
doi: 10.1088/1361-6498/ac5e50
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights reserved.

Auteurs

Marine Soret (M)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.
Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, LIB, F-75006 Paris, France.

Jacques-Antoine Maisonobe (JA)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.
Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, LIB, F-75006 Paris, France.

Stéphane Payen (S)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.

Adèle Gaubert (A)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.

Sandrine Brunel (S)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.

Sébastien Bergeret (S)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.

Arnaud Berenbaum (A)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.

Emilie Hubert (E)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.

Aurélie Kas (A)

AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Médecine Nucléaire, F-75013 Paris, France.
Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, LIB, F-75006 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH